Wu CY, Kao SE, Tseng YC, Lin YP, et al. Pilot-scale production of inactivated monoglycosylated split H(1)N(1) influenza virus vaccine provides cross-strain protection against influenza viruses. Antiviral Res 2023 May 30:105640. doi: 10.1016/j.antiviral.2023.105640.
PMID: 37263355